Positive results in recent animal study strongly support first-ever human investigation for DehydraTECH-liraglutide KELOWNA, ...

Lexaria Bioscience (LEXX) has released an update.Pick the best stocks and maximize your portfolio:Discover top-rated stocks from highly ranked ...

is planning to offer a generic version of Novo Nordisk's diabetes drug, liraglutide, to its platform in 2025, per a Reuters report. "We have already confirmed a core supplier for this addition and ...

Keep reading to learn more about Victoza and reproductive health. And for a detailed overview of this drug, check out this in-depth Victoza article. If you can become pregnant, it’s important to ...

Indian pharmaceutical companies, which benefited from sector tailwinds such as stable generic pricing and shortage-led opportunities and stable costs of raw materials in the past 18-24 months, will ...

The darlings of the weight loss and diabetes spaces, GLP-1 receptor agonists have shown promise against Alzheimer’s in recent studies—with Phase III results expected next year from Novo Nordisk.

Learn more about the metabolic effects of liraglutide treatment in individuals with type 2 diabetes and obesity.